Improved control of cisplatin‐induced emesis with high‐dose metoclopramide and with combinations of metoclopramide, dexamethasone, and diphenhydramine. Results of consecutive trials in 255 patients

Cancer

Volumn 55, Issue 3, 1985, Pages 527-534

  Kris, Mark G ^a   Gralla, Richard J ^a   Tyson, Leslie B ^a   Clark, Rebecca A ^a   Kelsen, David P ^a   Reilly, Laura K ^a   Groshen, Susan ^a   Bosl, George J ^a   Kalman, Leonard A ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DEXAMETHASONE; DIPHENHYDRAMINE; METOCLOPRAMIDE; MITOGUAZONE; VINBLASTINE; VINDESINE;

ADVERSE DRUG REACTION; CANCER CHEMOTHERAPY; DIARRHEA; DRUG COMPARISON; DRUG DOSE; DRUG EFFICACY; DRUG MIXTURE; DRUG THERAPY; DYSTONIA; GASTROINTESTINAL TOXICITY; HUMAN; INTOXICATION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; NERVOUS SYSTEM; NEUROTOXICITY; PREVENTION; PRIORITY JOURNAL; SEDATION; THERAPY; VOMITING;

ADULT; AGED; ANTIEMETICS; CISPLATIN; CLINICAL TRIALS; DEXAMETHASONE; DIPHENHYDRAMINE; DRUG THERAPY, COMBINATION; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; METOCLOPRAMIDE; MIDDLE AGED;

EID: 0021993784     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19850201)55:3<527::AID-CNCR2820550310>3.0.CO;2-2     Document Type: Article

References (26)

1. Antiemetic efficacy high‐dose metoclopramide: Randomized trials with placebo and prochlorperazine in patients with chemotherapy‐induced nausea and vomiting
2. Double‐blind placebo‐controlled study of metoclopramide
3. Intravenous metoclopramide: An effective antiemetic in cancer chemotherapy
4. High dose metoclopramide as an antiemetic for patients receiving chemotherapy with cisplatinum
5. Metoclopramide as an antiemetic in patients receiving cisplatin
6. Antiemetic efficacy of dexamethasone therapy in patients receiving cancer chemotherapy
7. A randomized, cross‐over comparison of the effectiveness of intravenous (IV) metoclopramide (MCP) and IV dexamethasone (DXM) as antiemetic prevention in cancer chemotherapy (CT)
8. Double‐blind crossover study of the antiemetic efficacy of high‐dose dexamethasone (DEX) vs. high‐dose metoclopramide (MCP)
9. Comparison of the antiemetic effect of high‐dose intravenous metoclopramide (M) and high‐dose intravenous haldol (H) in a randomized double‐blind crossover study
10. Delta‐9‐tetrahydrocannabinol as an antiemetic in cancer patients receiving high‐dose methotrexate: A prospective, randomized evaluation
11. Delta‐9‐tetrahydro‐cannabinol as an emetic for patients receiving cancer chemotherapy: A comparison with prochlorperazine and a placebo
12. Antiemetic effect of delta‐9‐tetrahydrocannabinol in patients receiving cancer chemotherapy
13. The pharmacology and clinical effectiveness of phenothiazines and related drugs for managing chemotherapy‐induced emesis
14. Antiemetics: Neurotransmitter receptor binding predicts therapeutic actions
15. Antagonism of cisplatin induced emesis in the dog
16. Metoclopramide: Initial clinical studies of high dose regimens in cisplatin‐induced emesis
17. Extrapyramidal reactions with high‐dose metoclopramide
18. Phase I study of metoclopramide in children
19. Vindesine: A review of phase II trials
20. Vinblastine in neoplastic disease
21. Methylglyoxal‐bis (guanylhydrazone) (methyl‐GAG): Current status and future prospects
22. The role of cisplatinum in solid tumor therapy
23. Cisplatin and vindesine combination chemotherapy for advanced carcinoma of the lung: A randomized trial investigating two dosage schedules
24. Cisplatin, vindesine, and bleomycin (DVB) combination chemotherapy for esophageal carcinoma
25. Toxic effects of cis‐dichlorodiammine platinum (II) in man
26. Optimizing metoclopramide control of cisplatin induced emesis